Insiders / Bredt David / Activity
Activity — Bredt David
10 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $222.7K | -8K -2.05% | 395,775 0.82% of shares | medium |
| Dec 31, 2025 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $197.3K | -7K -1.60% | 404,075 0.84% of shares | medium |
| Feb 17, 2026 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $156.3K | -5K -1.37% | 389,275 0.81% of shares | medium |
| Feb 17, 2026 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $65.1K | -2K -0.57% | 387,075 0.81% of shares | low |
| Feb 17, 2026 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $25.2K | -900 -0.23% | 394,675 0.82% of shares | low |
| Feb 19, 2026 | Exercise | RAPP Rapport Therapeutics, Inc. Common Stock | $10.8K | +6K +1.55% | 393,075 0.82% of shares | low |
| Jan 15, 2026 | Sell | RAPP Rapport Therapeutics, Inc. Common Stock | $5.5K | -200 -0.05% | 395,575 0.82% of shares | low |
| Feb 19, 2026 | Exercise | RAPP Rapport Therapeutics, Inc. Stock Options (Right to Buy) | — | -6K -6.38% | 88,080 0.18% of shares | low |
| Feb 2, 2026 | Grant | RAPP Rapport Therapeutics, Inc. Stock Option (Right to Buy) | — | +103K | 103,000 0.21% of shares | low |
| Dec 31, 2025 | Grant | RAPP Rapport Therapeutics, Inc. Common Stock | — | -18K -4.20% | 410,642 0.86% of shares | low |